PT-141 (Bremelanotide) 10mg

PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from the alpha-melanocyte-stimulating hormone (α-MSH). Unlike many compounds that act on the vascular system, PT-141 primarily targets the central nervous system, where it interacts with melanocortin receptors involved in sexual arousal and behavioral signaling pathways.

Research has explored PT-141 for its effects on neural pathways associated with libido, sexual motivation, and central arousal mechanisms. It is unique in that its mechanism of action is believed to be centrally mediated rather than dependent on peripheral blood flow, distinguishing it from other compounds studied in sexual health research.

Scientific investigations have focused on its interaction with melanocortin receptors, particularly MC3R and MC4R, which are involved in appetite regulation, energy balance, and sexual function. Ongoing research continues to evaluate its broader role in neurobehavioral signaling and central nervous system modulation.

For Research Use Only: PT-141 (Bremelanotide) is intended exclusively for laboratory and scientific research purposes. It has not been approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, mitigation, or prevention of any disease outside of approved clinical indications. References to biological activity, mechanisms, and research findings are provided solely for educational and scientific discussion.

Potential Research Applications:

• Sexual behavior and libido research

• Central nervous system melanocortin pathway studies

• Neuroendocrine signaling investigations

• Motivation and reward pathway research

• Behavioral neuroscience studies

• Appetite and energy balance research (MC4R-related pathways)

• Hypothalamic signaling research

  
  

Mechanisms Under Investigation:

• Activation of melanocortin receptors (MC3R and MC4R)

• Modulation of hypothalamic signaling pathways

• Central nervous system regulation of sexual arousal

• Interaction with dopamine-mediated reward circuits

• Influence on neuroendocrine behavioral responses

• Independent of peripheral vascular mechanisms

  
  

PT-141 continues to be studied for its unique central mechanism of action and its role in melanocortin system signaling. Research remains ongoing into its broader implications for neurobehavioral science and central regulatory pathways.

Compliance Disclaimer: For Research Use Only. PT-141 (Bremelanotide) is an investigational research compound and is not approved by the FDA for the diagnosis, treatment, cure, mitigation, or prevention of any disease. Any references to libido, sexual function, neural signaling, or behavioral effects are derived from scientific research and are provided solely for educational purposes. These statements should not be interpreted as claims of safety, efficacy, or therapeutic benefit outside approved medical use. Use must comply with all applicable laws, regulations, and research protocols.